Track General Biologicals's inventory ($54M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest inventory for 4117.TWO is $54M as of June 2026. That compares with $72M in the prior-year period — down 24.9% year over year. Investors often review this figure alongside General Biologicals's historical trend and sector peers before judging valuation or financial health.
Over the past year, 4117.TWO's inventory moved from $72M to $54M — a 24.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in General Biologicals's operating scale or balance-sheet position.
A inventory figure of $54M for 4117.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 4117.TWO's inventory ($54M), review year-over-year change from $72M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.